Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Samit Patel

Pediatric Gastroenterology Orlando, FL Medical Doctor

NPI 1427459163 CMS profile 5698460

615 E Princeton St Ste 225, Orlando, FL 32803

Open in the dashboard

General payments

$6,788

125 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Samit Patel of Orlando, FL is reported in the CMS Open Payments database as having received $6,788 across 125 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,070 16
2024 General $2,884 38
2023 General $839 29
2022 General $703 14
2021 General $850 23
2020 General $127 2
2019 General $315 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Samit Patel
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Samit Patel were reported at $1,070. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Samit Patel Pediatric Gastroenterology median Middle half National median
2019 $315 $131 $41–$311 $163
2020 $127 $79 $23–$223 $114
2021 $850 $104 $32–$321 $132
2022 $703 $125 $37–$331 $149
2023 $839 $169 $55–$440 $160
2024 $2,884 $196 $73–$563 $164
2025 $1,070 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $2,512 26 payments
  2. Coloplast Corp $808 18 payments
  3. AbbVie, Inc. $659 10 payments
  4. Innovative Health Solutions, Inc. $509 4 payments
  5. Mirum Pharmaceuticals, Inc. $314 4 payments
  6. QOL Medical, LLC $291 11 payments
  7. Janssen Scientific Affairs, LLC $241 2 payments
  8. Nestle HealthCare Nutrition Inc. $200 10 payments
  9. Phadia US Inc. $156 4 payments
  10. Regeneron Healthcare Solutions, Inc. $132 7 payments
  11. Other $967 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,632 124 payments
  2. Consulting Fee $1,156 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $2,512 26 payments
  2. Peristeen $687 14 payments
  3. Livmarli $314 4 payments
  4. STELARA $241 2 payments
  5. DUPIXENT Inflammation And Immunology $208 7 payments
  6. ZENPEP $200 10 payments
  7. Sucraid $192 7 payments
  8. HUMIRA $184 5 payments
  9. ImmunoCAP $156 4 payments
  10. CREON $134 2 payments
  11. Other $1,217 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

125 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record